In the present study, the above-mentioned methods were combined, and four potential tumor antigens (HLTF, ITGA10, PLCG1, and TTC3) were identified by screening key genes that were amplified, mutated, and overexpressed. This evidence concerns the gene PLCG1 and neoplasm.